We provide you with 20 years of free, institutional-grade data for TEM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TEM. Explore the full financial landscape of TEM stock.
| Reported Date | Ticker | Type | |
|---|---|---|---|
| 2026-05-05 | TEM | 10-Q | Url |
| 2026-02-24 | TEM | 10-K | Url |
| 2025-11-04 | TEM | 10-Q | Url |
| 2025-08-08 | TEM | 10-Q | Url |
| 2025-05-06 | TEM | 10-Q | Url |
| 2025-02-25 | TEM | S-1 | Url |
| 2025-02-24 | TEM | 10-K | Url |
| 2024-11-04 | TEM | 10-Q | Url |
| 2024-08-06 | TEM | 10-Q | Url |
| 2024-05-20 | TEM | S-1 | Url |
Tempus AI, Inc(:TEM)
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology c...
The information provided in this report about TEM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.